Ranirestat for the Management of Diabetic Sensorimotor Polyneuropathy

OBJECTIVE: Aldose reductase inhibitors (ARIs) are potential disease modifiers for diabetes complications. We aimed to determine whether ranirestat, an ARI, could slow or reverse the course of diabetic sensorimotor polyneuropathy (DSP). RESEARCH DESIGN AND METHODS: A total of 549 patients with DSP we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bril, Vera, Hirose, Toshiyuki, Tomioka, Sasagu, Buchanan, Robert
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699746/
https://www.ncbi.nlm.nih.gov/pubmed/19366965
http://dx.doi.org/10.2337/dc08-2110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699746/
https://www.ncbi.nlm.nih.gov/pubmed/19366965
http://dx.doi.org/10.2337/dc08-2110

Ejemplares similares